Literature DB >> 22207317

Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?

Carey E Gleason1, N Maritza Dowling, Elliot Friedman, Whitney Wharton, Sanjay Asthana.   

Abstract

OBJECTIVE: This study investigated the phenomenon known as the healthy user bias by equating hormone therapy (HT) use (past or current) with healthy user status.
METHODS: Data from the Survey of Midlife in the United States were used to identify the predictors of HT use. The unique Survey of Midlife in the United States data include psychological, demographic, health-related, and behavioral variables as well as history of HT use. Predictors of HT use were combined to derive propensity scores, describing the likelihood that a woman was an HT user, based on her psychological, demographic, physical, and behavioral profile (ie, likelihood of being a healthy user) as opposed to her actual use of HT. Finally, cognitive performance on an executive function test was examined in women stratified by propensity score.
RESULTS: Using a multiple logistic regression model, nine variables emerged as predictors of HT use. The nine variables were used to estimate the propensity or conditional probability of using HT for each subject; resultant propensity scores were ranked and divided into tertiles. Women in the highest tertile demonstrated shorter median response latencies on a test of executive function than did women who did not use HT.
CONCLUSIONS: From an array of psychological, medical, and behavioral variables, nine emerged as predictors of HT use. If validated, these features may serve as a means of estimating the phenomenon known as healthy user bias. Moreover, these data suggest that the degree to which a woman fits a model of a healthy user may influence cognitive response to HT.

Entities:  

Mesh:

Year:  2012        PMID: 22207317      PMCID: PMC3326437          DOI: 10.1097/gme.0b013e318238ff2c

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  36 in total

Review 1.  Estrogen replacement therapy for the potential treatment or prevention of Alzheimer's disease.

Authors:  M M Miller; A A Monjan; N S Buckholtz
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

2.  Planning for the future: a life management strategy for increasing control and life satisfaction in adulthood.

Authors:  K M Prenda; M E Lachman
Journal:  Psychol Aging       Date:  2001-06

3.  Hormone therapy and risk of Alzheimer disease: a critical time.

Authors:  Susan M Resnick; Victor W Henderson
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

4.  Estrogen and cognition: a true relationship?

Authors:  Sanjay Asthana
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

5.  Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome.

Authors:  Antonia M W Coppus; Heleen M Evenhuis; Gert-Jan Verberne; Frank E Visser; Piet Eikelenboom; Willem A van Gool; A Cecile J W Janssens; Cornelia M van Duijn
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women.

Authors:  F B Hu; M J Stampfer; J E Manson; F Grodstein; G A Colditz; F E Speizer; W C Willett
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

Review 7.  The role of hormone replacement therapy in the prevention of Alzheimer disease.

Authors:  Howard M Fillit
Journal:  Arch Intern Med       Date:  2002-09-23

8.  Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Stephen R Rapp; Mark A Espeland; Sally A Shumaker; Victor W Henderson; Robert L Brunner; JoAnn E Manson; Margery L S Gass; Marcia L Stefanick; Dorothy S Lane; Jennifer Hays; Karen C Johnson; Laura H Coker; Maggie Dailey; Deborah Bowen
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

9.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  6 in total

Review 1.  Effects of hormone therapy on cognition and mood.

Authors:  Barbara Fischer; Carey Gleason; Sanjay Asthana
Journal:  Fertil Steril       Date:  2014-04       Impact factor: 7.329

Review 2.  Psychological well-being revisited: advances in the science and practice of eudaimonia.

Authors:  Carol D Ryff
Journal:  Psychother Psychosom       Date:  2013-11-19       Impact factor: 17.659

Review 3.  Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.

Authors:  Jacqueline O'Brien; John W Jackson; Francine Grodstein; Deborah Blacker; Jennifer Weuve
Journal:  Epidemiol Rev       Date:  2013-09-15       Impact factor: 6.222

Review 4.  Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

Authors:  Jia Yao; Roberta Diaz Brinton
Journal:  Adv Pharmacol       Date:  2012

5.  Aging Well Among Women Veterans Compared With Non-Veterans in the Women's Health Initiative.

Authors:  Andrea Z LaCroix; Eileen Rillamas-Sun; Nancy F Woods; Julie Weitlauf; Oleg Zaslavsky; Regina Shih; Michael J LaMonte; Chloe Bird; Elizabeth M Yano; Meryl LeBoff; Donna Washington; Gayle Reiber
Journal:  Gerontologist       Date:  2016-02

6.  Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities.

Authors:  Molly M Shores; Thomas J Walsh; Anna Korpak; Chloe Krakauer; Christopher W Forsberg; Alexandra E Fox; Kathryn P Moore; Susan R Heckbert; Mary Lou Thompson; Nicholas L Smith; Alvin M Matsumoto
Journal:  J Am Heart Assoc       Date:  2021-08-21       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.